| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
23,725 |
20,203 |
$1.83M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
304 |
284 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,008 |
2,751 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
307 |
286 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,754 |
9,490 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
21 |
20 |
$0.00 |
| 87807 |
|
15 |
15 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
18 |
17 |
$0.00 |
| 96127 |
|
31 |
31 |
$0.00 |
| 81002 |
|
768 |
717 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,616 |
2,298 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,006 |
1,910 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,029 |
2,850 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
635 |
607 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
651 |
632 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
304 |
293 |
$0.00 |
| 81025 |
|
28 |
26 |
$0.00 |